|
1
|
Jemal A, Murray T, Ward E, et al: Cancer
statistics. CA Cancer J Clin. 59:225–249. 2009.
|
|
2
|
Lengauer C, Kinzler K and Vogelstein B:
Genetic instabilities in human cancers. Nature. 396:643–649. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Baylin S and Ohm J: Epigenetic gene
silencing in cancer - a mechanism for early oncogenic pathway
addiction? Nat Rev Cancer. 6:107–116. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Esteller M: Cancer epigenomics: DNA
methylomes and histone-modification maps. Nat Rev Genet. 8:286–298.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang E and Wicha M: Colon cancer stem
cells: implications for prevention and therapy. Trends Mol Med.
14:503–509. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pardal R, Clarke M and Morrison S:
Applying the principles of stem-cell biology to cancer. Nat Rev
Cancer. 3:895–902. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tan B, Park C, Ailles L and Weissman I:
The cancer stem cell hypothesis: a work in progress. Lab Invest.
86:1203–1207. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen Y, Hsu H, Chen Y, et al: Oct-4
expression maintained cancer stem-like properties in lung
cancer-derived CD133-positive cells. PLoS One. 3:e26372008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gangemi R, Griffero F, Marubbi D, et al:
SOX2 silencing in glioblastoma tumor-initiating cells causes stop
of proliferation and loss of tumorigenicity. Stem Cells. 27:40–48.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Todaro M, Alea M, Stefano DA, et al: Colon
cancer stem cells dictate tumor growth and resist cell death by
production of interleukin-4. Cell Stem Cell. 1:389–402. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gregory RI, Yan KP, Amuthan G, et al: The
microprocessor complex mediates the genesis of microRNAs. Nature.
432:235–240. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bernstein E, Caudy A, Hammond SM and
Hannon GJ: Role for a bidentate ribonuclease in the initiation step
of RNA interference. Nature. 409:363–366. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Meister G and Tuschl T: Mechanisms of gene
silencing by double-stranded RNA. Nature. 431:343–349. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Peters L and Meister G: Argonaute
proteins: mediators of RNA silencing. Mol Cell. 26:611–623. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Harfe BD, McManus M, Mansfield JH,
Hornstein E and Tabin CJ: The RNaseIII enzyme Dicer is required for
morphogenesis but not patterning of the vertebrate limb. Proc Natl
Acad Sci USA. 102:10898–10903. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Murchison EP, Stein P, Xuan ZY, et al:
Critical roles for Dicer in the female germline. Genes Dev.
21:682–693. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Y, Medvid R, Melton C, Jaenisch R and
Blelloch R: DGCR8 is essential for microRNA biogenesis and
silencing of embryonic stem cell self-renewal. Nat Genet.
39:380–385. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wienholds E, Koudijs MJ, Eeden F, Cuppen E
and Plasterk R: The microRNA-producing enzyme Dicer1 is essential
for zebrafish development. Nat Genet. 35:217–218. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li J, Chen YX, Zhao JF, Kong FR and Zhang
YD: miR-203 reverses chemoresistance in p53-mutated colon cancer
cells through downregulation of Akt2 expression. Cancer Lett.
304:52–59. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Strillacci A, Griffonia C, Sansone P, et
al: MiR-101 downregulation is involved in cyclooxygenase-2
overexpression in human colon cancer cells. Exp Cell Res.
315:1439–1447. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li P, Lu XM, Wang YY, et al: MiR181-b
suppresses proliferation of and reduces chemoresistance to
temozolomide in U87 glioma stem cells. J Biomed Res. 24:436–443.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li X, Pan YZ, Seigel GM, et al: Breast
cancer resistance protein BCRP/ABCG2 regulatory microRNAs
(hsa-miR-328, -519c and -520h) and their differential expression in
stem-like ABCG2+ cancer cells. Biochem Pharmacol.
81:783–792. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang HL, Li WH, Nan FF, et al: MicroRNA
expression profile of colon cancer stem-like cells in HT29
adenocarcinoma cell line. Biochem Biophys Res Commun. 404:273–278.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Seger R and Krebs EG: The MAPK signaling
cascade. FASEB J. 726–735. 1995.
|
|
27
|
Polakis P: Wnt signaling and cancer. Genes
Dev. 14:1837–1851. 2000.
|
|
28
|
Kasper G, Mao L, Geissler S, Draycheva A,
Trippens J, Kühnisch J, Tschirschmann M, Kaspar K, Perka C, Duda GN
and Klose J: Insights into mesenchymal stem cell aging: involvement
of antioxidant defense and actin cytoskeleton. Stem Cells.
27:1288–1297. 2009. View
Article : Google Scholar : PubMed/NCBI
|
